Esoteric Testing Market Regional Analysis

North America region in the market accounted for 31.22% in 2023. Government subsidies for high quality healthcare, availability of coverage, increased purchasing power, increased incidence of infections and diseases such as cancer are important enhancers in this category. This can be attributed to the anticipated growth of the market owing to well-established healthcare infrastructure, increased purchasing power and moving occult test approval rates. The esoteric testing market in the U.S. is expected to grow slightly and is expected to increase during the forecast period owing to healthcare initiatives, rising prevalence of diabetes and favorable conditions for market expansion in the country.

Asia-Pacific in the market was anticipated to witness substantial growth during the forecast period. Additionally, developing countries such as India and China have opportunities for growth due to high patient volumes and increasing number of established healthcare providers, healthcare utilization trends the front comes from increased government support for chronic disease diagnosis and treatment. China's healthcare system is facing a severe test due to rising healthcare costs and high spending. In addition, a growing number of government programs aimed at providing diagnostic services, rapid development of enzyme-linked immunoassay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR) are expected to drive market growth in China.